Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Applied Therapeutics, Inc. (APLT) stock rallied over 2.89% intraday to trade at $0.89 a share on NASDAQ. The stock opened with a loss of -5.32% at $0.885 and touched an intraday high of $0.92, rising 2.89% against the last close of $0.865. The stock went to a low of $0.86 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-05 | $0.885 | $0.92 | $0.86 | $0.89 | 428,953 |
2022-07-01 | $0.94 | $0.94 | $0.859 | $0.865 | 401,200 |
2022-06-30 | $0.92 | $0.97 | $0.845 | $0.948 | 1,568,600 |
2022-06-29 | $0.86 | $0.9 | $0.809 | $0.88 | 2,313,000 |
2022-06-28 | $0.805 | $0.931 | $0.728 | $0.891 | 4,654,200 |
2022-06-27 | $0.87 | $0.87 | $0.801 | $0.81 | 839,100 |
2022-06-24 | $0.84 | $0.845 | $0.775 | $0.845 | 2,863,900 |
2022-06-23 | $0.814 | $0.839 | $0.74 | $0.76 | 2,401,300 |
2022-06-22 | $1.06 | $1.2 | $0.99 | $1.07 | 924,900 |
2022-06-21 | $1.1 | $1.1 | $1.03 | $1.04 | 217,700 |
Employees-
Beta-
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Applied Therapeutics, Inc. (NASDAQ: APLT) stock price is $0.89 as of the last check on Tuesday, July 5. During the trading session, APLT stock reached the peak price of $0.92 while $0.86 was the lowest point it dropped to.
The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Health Care sector. Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications.
Dr. Charles Silberstein M.D., CFA
CFO & Head of Bus. Devel.
Mr. Chids Mahadevan
VP of Fin. & Chief Accounting Officer
Dr. Shoshana Shendelman Ph.D.
Chair of the Board of Directors, Founder, Pres, CEO & Sec.
Dr. Riccardo Perfetti M.D., Ph.D.
Chief Medical Officer
APLT stock traded closed the last session at $0.89, which is $0.02 or 2.89% lower than its previous close of $0.865. APLT's current trading price is 22.30% lower than its 52-week high of $22.27 where as its distance from 52-week low of 0.73% is -96.00%.
Number of APLT employees currently stands at -. APLT operates from 545 Fifth Avenue, Suite 1400, New York, NY 10017, United States.
Official Webiste of $APLT is: https://www.appliedtherapeutics.com
APLT could be contacted at APLT operates from 545 Fifth Avenue, Suite 1400, New York, NY 10017, United States, or at phone #212 220 9226 and can also be accessed through its website.
APLT stock volume for the day was 449,410 shares while in the previous session number of APLT shares traded was 428,953 . The average number of APLT shares traded daily for last 3 months was 420.25 Thousands.
The percentage change in APLT stock occurred in the recent session was 2.89% while the dollar amount for the price change in APLT stock was $0.02.
In the recent session, the day high for APLT stock was $0.92 while the low for APLT stock touched on the day was $0.86.
The market value of APLT currently stands at 25.62 Million with its latest stock price at $0.89 and 26.22 Million of its shares outstanding.